Sodium-phosphate cotransporters, nephrolithiasis and bone demineralization

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 6, 2004, Pages 675-681

  Prié, Dominique ^a,b   Beck, Laurent ^a   Friedlander, Gérard ^a,b   Silve, Caroline ^a  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Calcitriol; Calcium; Fibre blast growth factor 23; Kidney; Phosphate; Renal tubule

Indexed keywords

COTRANSPORTER; FIBROBLAST GROWTH FACTOR 2; GENE PRODUCT; OXYGENASE; SODIUM PHOSPHATE COTRANSPORTER 2A; SODIUM PROTON EXCHANGER REGULATORY FACTOR 1 PROTEIN; UNCLASSIFIED DRUG;

BONE DEMINERALIZATION; CALCIUM STONE; GENE MUTATION; HETEROZYGOTE; HUMAN; HYPERCALCIURIA; HYPOPHOSPHATEMIA; NEPHROLITHIASIS; NONHUMAN; OSTEOMALACIA; PATHOGENESIS; PHOSPHATE EXCRETION; PHOSPHATE METABOLISM; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RICKETS; RISK FACTOR; SEX DIFFERENCE; SPECIES DIFFERENCE; URINARY EXCRETION;

ANIMALS; BONE DEMINERALIZATION, PATHOLOGIC; CALCIUM; FEMALE; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HUMANS; KIDNEY CALCULI; MALE; MICE; PHOSPHATES; PROTON-PHOSPHATE SYMPORTERS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS;

EID: 8644278672     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200411000-00015     Document Type: Review

References (40)

1. Suki WN, Lederer ED, Rouse D. Renal transport of calcium, magnesium, and phosphate. In: Brenner BM, editor. The kidney, 6th ed. Philadelphia: W.B. Saunders Company; 2000. pp. 520-574.
2. Tenenhouse HS, Sabbagh Y. Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders. Pflugers Arch 2002; 444:317-326.
3. Quarles LD. Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest 2003; 112:642-646.
4. Bowe AE, Finnegan R, Jan de Beur SM, et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 2001; 284:977-981.
5. Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001; 98:6500-6505.
6. +-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 2003; 278:2206-2211. This interesting study describes the effects of a mutant FGF23 protein on phosphate transporters and on vitamin D metabolism without altering PTH secretion.
7. Shimada T, Kakitani M, Yamazaki Y, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113:561-568. This report provides a description of the phenotype of FGF23-null mice.
8. Murer H, Hernando N, Forster I, et al. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 2000; 80:1373-1409.
9. Silve C, Friedlander G. Hypo and hyperphosphataemia. In: Grunfeld JP, Ypersele MV, Cameron JS, et al., editors. Oxford textbook of clinical nephrology, 3rd ed. Oxford: Oxford University Press; 2004 (in press).
10. Biber J, Custer M, Wemer A, et al. Localization of NaPi-1, a Na/Pi cotransporter, in rabbit kidney proximal tubules. II. Localization by immunohistochemistry. Pflugers Arch 1993; 424:210-215.
11. Busch AE, Schuster A, Waldegger S, et al. Expression of a renal type I sodium/phosphate transporter (NaPi-1) induces a conductance in Xenopus oocytes permeable for organic and inorganic anions. Proc Natl Acad Sci USA 1996; 93:5347-5351.
12. Hiffiker H, Hattenhauer O, Traebert M, et al. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA 1998; 95:14564-14569.
13. +-Pi) transporter (SLC34A2). Genomics 1999; 62:281-284.
14. +-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3. Biochem J 1999; 343 (Pt 3):705-712.
15. 3. Am J Physiol Cell Physiol 2002; 282:C487-C493.
16. Segawa H, Kaneko I, Takahashi A, et al. Growth-related renal type II Na/Pi cotransporter. J Biol Chem 2002; 277:19665-19672.
17. -/- and Hyp mice.
18. Beck L, Karaplis AC, Amizuka N, et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 1998; 95:5372-5377.
19. Khundmiri SJ, Rane MJ, Lederer ED. Parathyroid hormone regulation of type II sodium-phosphate cotransporters is dependent on an A kinase anchoring protein. J Biol Chem 2003; 278:10134-10141. This study demonstrates that NPT2a is physically associated with an A kinase anchoring protein and that this association is necessary for regulation of phosphate transport by PTH.
20. Shenolikar S, Voltz JW, Minkoff CM, et al. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc Natl Acad Sci USA 2002; 99:11470-11475.
21. Gisler SM, Stagljar I, Traebert M, et al. Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. J Biol Chem 2001; 276:9206-9213.
22. Hernando N, Deliot N, Gisler SM, et al. PDZ-domain interactions and apical expression of type IIa Na/P(i) cotransporters. Proc Natl Acad Sci USA 2002; 99:11957-11962.
23. Gupta A, Guo XL, Alvarez UM, et al. Regulation of sodium-dependent phosphate transport in osteoclasts. J Clin Invest 1997; 100:538-549.
24. +-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2-/- mice. Bone 2001; 29:467-476.
25. +-dependent phosphate transporters in the murine osteoclast: cellular distribution and protein interactions. Am J Physiol Cell Physiol 2003; 284:C1633-C1644. This paper indicates that in mouse osteoclast NPT2a interacts with NHERF1 in a different manner than that reported in the kidney.
26. Salaun C, Rodrigues P, Heard JM. Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor. J Virol 2001; 75:5584-5592.
27. +-phosphate cotransporter genes in murine kidney. Am J Physiol 1998; 275:F527-F534.
28. Palmer G, Zhao J, Bonjour J, et al. In vivo expression of transcripts encoding the Glvr-1 phosphate transporter/retrovirus receptor during bone development. Bone 1999; 24:1-7.
29. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87:E10-E17.
30. Kavanaugh MP, Miller DG, Zhang W, et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91:7071-7075.
31. Bushinsky DA, Parker WR, Asplin JR. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 2000; 57:550-560.
32. Evan AP, Lingeman JE, Coe FL, et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111:607-616. The authors performed biopsies of plaques in kidneys of idiopathic calcium stone formers and confirmed Randall's hypothesis, according to which calcium renal stones originate in the basement membranes of the thin loops of Henle as apatite crystals, and then spread from there through the interstitium to beneath the urothelium.
33. Prie D, Ravery V, Boccon-Gibod L, et al. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60:272-276.
34. Chau H, El-Maadawy S, McKee MD, et al. Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res 2003; 18:644-657. This paper reports that NFT2a gene ablation in mice is associated with calcium renal stone formation.
35. Prie D, Huart V, Bakouh N, et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 2002; 347:983-991.
36. -/- mice.
37. Larsson T, Marsell R, Schipani E, et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha 1(I) collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis, Endocrinology 2004; 145:3087-3094, This paper describes the phenotype of a mouse strain that overexpresses FGF23.
38. Mansfield K, Rajpurohit R, Shapiro IM. Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes. J Cell Physiol 1999; 179:276-286.
39. Adams CS, Mansfield K, Perlot RL, et al. Matrix regulation of skeletal cell apoptosis. Role of calcium and phosphate ions. J Biol Chem 2001; 276:20316-20322.
40. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 14 (suppl 4):S300-S304. This interesting paper reviews data suggesting that PiT-1 may play a central role in formation of vascular calcification in the presence of high extracellular phosphate concentration.